Target-enhanced whole-genome sequencing (TE-WGS) shows clinical validity equivalent to commercially available targeted oncology panel
Sangmoon Lee, Jin Roh, Jun Sung Park, İslam Oğuz Tuncay, Won‐Chul Lee, Jung‐Ah Kim, Brian Baek-Lok Oh, Jong-Yeon Shin, Jeong Seok Lee, Young Seok Ju, Ryul Kim, Seongyeol Park, Jaemo Koo, Hansol Park, Joonoh Lim, , Minsuk Kwon
This study compares target-enhanced whole-genome sequencing (TE-WGS) with a commercial targeted panel, showing TE-WGS detects all variants and provides additional clinical insights.
Cancer Research and Treatment · Sep 19, 2024Peer-reviewedGenetic & Genomic Medicine